Literature DB >> 26218411

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.

Catherine Orrell1, Karen Cohen, Katya Mauff, David R Bangsberg, Gary Maartens, Robin Wood.   

Abstract

BACKGROUND: There are conflicting findings about whether mobile phone text message reminders impact on antiretroviral adherence. We hypothesized that text reminders sent when dosing was late would improve adherence and HIV viral suppression.
METHODS: Antiretroviral therapy (ART)-naive participants, from a South African outpatient ART clinic, were randomized to standard of care (SoC, 3 pretreatment education sessions), or intervention (SoC and automated text reminders if dosing >30 minutes late). Dosing time was recorded by real-time electronic adherence monitoring devices, given to participants at ART start. CD4 cell count and HIV RNA were determined at baseline, 16 and 48 weeks. Primary outcome was cumulative adherence execution by electronic adherence monitoring device. HIV-1 viral suppression (<40 copies/mL) at week 48 and count of treatment interruptions (TIs) >72 hours were secondary outcomes. Analysis was by intention to treat (missing = failure). Registration was with the Pan-African Clinical Trials Registry: PACTR201311000641402.
RESULTS: A total of 230 participants were randomly assigned to control (n = 115) or intervention (n = 115) arms. Median adherence was 82.1% (interquartile range, 56.6%-94.6%) in the intervention arm, compared with 80.4% (interquartile range, 52.8%-93.8%) for SoC [adjusted odds ratio for adherence 1.08; 95% confidence interval (CI): 0.77 to 1.52]. Suppressed HIV RNA (<40 copies/mL) occurred in 80 (69.6%) of control and 75 (65.2%) of intervention (adjusted odds ratio for virological failure in intervention arm 0.77; 95% CI: 0.42 to 1.40). In the intervention arm, the count of TIs of >72 hours was reduced (adjusted incident rate ratio, 0.84; 95% CI: 0.75 to 0.94).
CONCLUSIONS: Text message reminders linked to late doses detected by real-time adherence monitoring reduced the number of prolonged TIs, but did not significantly improve adherence or viral suppression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26218411     DOI: 10.1097/QAI.0000000000000770

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  56 in total

Review 1.  Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances.

Authors:  Jeffrey I Campbell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

2.  If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.

Authors:  Alissa Davis; Lyailya Sarsembayeva; Valeriy Gulyaev; Sholpan Primbetova; Assel Terlikbayeva; Gaukhar Mergenova; Robert H Remien
Journal:  AIDS Behav       Date:  2019-12

Review 3.  Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.

Authors:  Kate M Bell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-10       Impact factor: 5.071

4.  A validated liquid chromatography/tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from human immunodeficiency virus infected patients.

Authors:  Jenna Johnston; Catherine Orrell; Peter Smith; Anton Joubert; Lubbe Wiesner
Journal:  Rapid Commun Mass Spectrom       Date:  2018-04-30       Impact factor: 2.419

Review 5.  Content guidance for mobile phones short message service (SMS)-based antiretroviral therapy adherence and appointment reminders: a review of the literature.

Authors:  Andrew Kerrigan; Nadi N Kaonga; Alice M Tang; Michael R Jordan; Steven Y Hong
Journal:  AIDS Care       Date:  2018-11-29

6.  A Systematic Review on Promoting Adherence to Antiretroviral Therapy in HIV-infected Patients Using Mobile Phone Technology.

Authors:  Yuri Quintana; Eduardo A Gonzalez Martorell; Darren Fahy; Charles Safran
Journal:  Appl Clin Inform       Date:  2018-06-20       Impact factor: 2.342

7.  Retention in HIV Care Among HIV-Seropositive Pregnant and Postpartum Women in Uganda: Results of a Randomized Controlled Trial.

Authors:  Lora L Sabin; Nafisa Halim; Davidson H Hamer; Elizabeth M Simmons; Sivani Jonnalagadda; Anna Larson Williams; Harriet Chemusto; Allen L Gifford; Rachael Bonawitz; Philip Aroda; Mary DeSilva; Julia Gasuza; Barbara Mukasa; Lisa J Messersmith
Journal:  AIDS Behav       Date:  2020-11

8.  Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring.

Authors:  Jessica E Haberer; Nicholas Musinguzi; Alexander C Tsai; Yap Boum; Bosco M Bwana; Conrad Muzoora; Peter W Hunt; Jeffrey N Martin; David R Bangsberg
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

9.  The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda.

Authors:  Jeffrey I Campbell; Angella Musiimenta; Bridget Burns; Sylvia Natukunda; Nicholas Musinguzi; Jessica E Haberer; Nir Eyal
Journal:  AIDS Care       Date:  2018-12-09

Review 10.  Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.

Authors:  Jose R Castillo-Mancilla; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2018-02       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.